about
Stromal cells control soluble material and cellular transport in lymph nodesRescue of TRAF3-null mice by p100 NF-kappa B deficiencyZinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strengthHuman mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways.CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice.High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses.Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.Identification of a new stromal cell type involved in the regulation of inflamed B cell folliclesTGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturationNovel treatment strategies for aggressive non-Hodgkin's lymphoma.Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.Hodgkin's lymphoma: molecular targets and novel treatment strategies.Genetic defects in common variable immunodeficiencyThe BLyS family: toward a molecular understanding of B cell homeostasis.BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.Hepatitis C virus infection and mixed cryoglobulinemiaThe role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model.Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis.Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients.Alum/Toll-Like Receptor 7 Adjuvant Enhances the Expansion of Memory B Cell Compartment Within the Draining Lymph Node.CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
P2860
Q21131218-7290361D-5A13-4C47-9910-FBDBDDDC289BQ28506895-FD0E34FE-C51F-4B3D-9F3F-4942B23AE354Q28508723-01859631-6716-4CD5-A280-BD5D3844456EQ30499055-CA97981B-0E85-4A82-870A-7FF2CBF310F6Q33364310-BF89A1FC-B745-42F9-9357-7B2C7DB38624Q33373525-3405EF12-5575-4CC0-87C7-37B731824E44Q33390753-7036B184-792C-43B2-A81D-CEC473DA6B79Q33416004-1CD3E617-0015-4EB6-8F8B-2174101BBEE2Q34294206-0AE8B07C-5655-46D4-9131-1538B33CDA63Q34514923-97F88FAA-8EF4-436D-9E17-3C7511687E16Q35017978-6A64CDA3-4EE5-47AB-B280-9497C38AB00FQ35163864-424B629F-753A-44A2-A292-A0A844466134Q35576420-A1AB8AF0-0CA0-4995-82FC-0E69F5B4A586Q36429727-197BDEF7-4376-45A4-ACCE-552A00836746Q36488962-7D8FD564-43D3-4D99-95E6-858D470A1933Q36572545-DEE2D1B2-C2D7-4E7D-A70C-F169D3A11AF3Q36879648-E2026A3E-8D59-4A43-9E40-CF519E99AD3FQ37335169-6A49A5DA-FE2D-4347-9B4D-DFADB55BDE2BQ37495356-30D6D9D7-ECE1-4036-B82C-1D1683D1437DQ37552017-AEA93A1E-83E3-4B3A-9273-8C918EE52DE2Q38030533-07282421-AACA-4F81-999C-8C80AFD436A8Q38106745-C1804E61-717D-4907-A353-8D17740BBEEBQ38260032-0572932A-F7DE-4046-A0F1-E5A5B19C7437Q38604547-65066E46-517C-4255-A621-672B4D4A3FA8Q38903921-9784E7D0-47D1-4E5A-BF18-A4AEFC4575CFQ38961202-EFB8AF11-589F-46F3-B969-CE78EA7B9E1EQ39389106-89602C5A-8701-46CE-9EDF-970B975DC13DQ39434173-C3B41D24-1FA3-4CEC-9587-8639750ABBBEQ39729327-2ACE440E-5900-47E3-AC09-3DDA9C666D35Q40789497-8C0FD51C-56C7-43E4-99FF-4AC8228A8629Q44915646-FCA817F2-A483-4702-BC89-445ED2018488Q52568335-041B69AA-1CA2-4A0A-83A7-A9593C78E12AQ58580403-A81E3B16-5279-4A88-A9C8-7892DA1CE612
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
BAFF and the regulation of B cell survival.
@ast
BAFF and the regulation of B cell survival.
@en
type
label
BAFF and the regulation of B cell survival.
@ast
BAFF and the regulation of B cell survival.
@en
prefLabel
BAFF and the regulation of B cell survival.
@ast
BAFF and the regulation of B cell survival.
@en
P1433
P1476
BAFF and the regulation of B cell survival.
@en
P2093
Pascal Schneider
P356
10.1016/S0165-2478(03)00050-6
P50
P577
2003-07-01T00:00:00Z